Immediate Impact

63 standout
Sub-graph 1 of 25

Citing Papers

The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
The interaction of innate immune and adaptive immune system
2024 Standout
2 intermediate papers

Works of Michele Montrone being referenced

Cisplatin/Pemetrexed Followed by Maintenance Pemetrexed Versus Carboplatin/Paclitaxel/Bevacizumab Followed by Maintenance Bevacizumab in Advanced Nonsquamous Lung Cancer: The GOIM (Gruppo Oncologico Italia Meridionale) ERACLE Phase III Randomized Trial
2014
Increased serum levels of the chemokine CXCL13 and up-regulation of its gene expression are distinctive features of HCV-related cryoglobulinemia and correlate with active cutaneous vasculitis
2008

Author Peers

Author Last Decade Papers Cites
Michele Montrone 223 188 170 178 55 684
Jonathan Cotliar 293 152 158 86 30 791
Feng Xiao 267 118 134 143 55 817
Jong‐Da Lian 121 106 219 155 39 773
Harvey Mendelow 143 228 117 61 37 761
Hiroaki Takeoka 227 150 241 212 43 711
Matteo Montani 94 109 311 256 44 811
Voigt Jj 231 66 87 77 35 614
Giuseppe Aimo 106 73 201 96 44 739
Arvind R. Murali 167 180 212 191 60 732
D. Fırat 190 128 141 30 46 669

All Works

Loading papers...

Rankless by CCL
2026